← HUMANA INC
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||||||||
| Net Income (Loss) Attributable to Parent | $614.0m | $2.4b | $1.7b | $2.7b | $3.4b | $2.9b | $2.8b | $2.5b | $1.2b | $1.2b | |
| Net Income (Loss) Attributable to Noncontrolling Interest | — | — | — | — | — | $1.0m | ($4.0m) | ($5.0m) | $7.0m | $15.0m | |
| Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | — | — | — | — | — | $2.9b | $2.8b | $2.5b | $1.2b | $1.2b | |
| Amortization | $77.0m | $75.0m | $90.0m | $70.0m | $88.0m | $73.0m | $96.0m | $67.0m | $60.0m | $51.0m | |
| Amortization of Intangible Assets | $77.0m | $75.0m | $90.0m | $70.0m | $88.0m | $65.0m | $81.0m | $67.0m | $60.0m | $51.0m | |
| Capitalized Computer Software, Amortization | $255.0m | $287.0m | $298.0m | $343.0m | $351.0m | $443.0m | $525.0m | $589.0m | $660.0m | $536.0m | |
| Deferred Policy Acquisition Costs, Amortization Expense | $67.0m | $71.0m | $48.0m | — | — | — | — | — | — | — | |
| Depreciation | $388.0m | $410.0m | $444.0m | $505.0m | $528.0m | $640.0m | $749.0m | $850.0m | $908.0m | $773.0m | |
| Depreciation and amortization | $388.0m | $410.0m | $444.0m | $505.0m | $528.0m | $640.0m | $749.0m | $779.0m | $839.0m | $698.0m | |
| Depreciation, Nonproduction | — | — | — | — | — | — | — | $831.0m | $884.0m | $753.0m | |
| Deferred Income Tax Expense (Benefit) | ($71.0m) | $132.0m | $194.0m | $162.0m | $195.0m | $15.0m | ($100.0m) | ($164.0m) | ($192.0m) | $75.0m | |
| Deferred income taxes | — | — | — | — | — | $15.0m | ($100.0m) | ($167.0m) | ($192.0m) | $75.0m | |
| Goodwill, Impairment Loss | — | — | — | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Impairment of Intangible Assets, Finite-lived | — | — | $12.0m | — | — | $0 | $0 | $55.0m | — | $128.0m | |
| Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) | — | — | — | — | — | $0 | $0 | $55.0m | $200.0m | $128.0m | |
| Impairment of indefinite-lived intangible assets | — | — | — | — | — | $0 | $0 | $55.0m | $200.0m | $128.0m | |
| Impairment of property and equipment | $0 | $2.0m | — | — | $0 | $0 | $248.0m | $210.0m | $7.0m | $23.0m | |
| Share-based Payment Arrangement, Expense | — | — | — | — | $181.0m | $180.0m | $216.0m | $175.0m | $207.0m | $241.0m | |
| Share-based Payment Arrangement, Noncash Expense | $115.0m | $157.0m | $137.0m | $163.0m | $181.0m | $180.0m | $216.0m | $175.0m | $207.0m | $241.0m | |
| Equity Method Investment, Realized Gain (Loss) on Disposal | — | — | ($90.0m) | ($62.0m) | ($838.0m) | $1.1b | $0 | $0 | ($24.0m) | $50.0m | |
| Gain (Loss) on Disposition of Business | $0 | $0 | ($786.0m) | $0 | $0 | — | $237.0m | $0 | $0 | ($67.0m) | |
| Income (Loss) from Equity Method Investments | — | — | $11.0m | $14.0m | $74.0m | $65.0m | ($4.0m) | ($63.0m) | ($94.0m) | ($102.0m) | |
| Income Tax Expense (Benefit) | $938.0m | $1.6b | $391.0m | $763.0m | $1.3b | $485.0m | $762.0m | $836.0m | $413.0m | $250.0m | |
| Interest Expense Nonoperating | — | — | — | — | — | — | — | — | $660.0m | $631.0m | |
| Other Nonoperating Income (Expense) | — | — | ($33.0m) | $506.0m | ($103.0m) | $532.0m | ($68.0m) | ($137.0m) | ($181.0m) | ($451.0m) | |
| Changes in operating assets and liabilities: | |||||||||||
| Additional Financial Items | |||||||||||
| (Payments) receipts from contract deposits, net | $1.1b | $1.8b | ($640.0m) | ($623.0m) | ($939.0m) | ($306.0m) | $2.0b | $828.0m | ($1.9b) | ($1.1b) | |
| (Repayments) proceeds from issuance of commercial paper, net | ($2.0m) | ($153.0m) | $485.0m | ($360.0m) | $295.0m | $352.0m | ($376.0m) | $211.0m | ($907.0m) | ($5.0m) | |
| Benefits payable | ($413.0m) | $105.0m | $252.0m | $1.1b | $2.1b | $104.0m | $975.0m | $915.0m | $199.0m | ($472.0m) | |
| Change in book overdraft | ($89.0m) | ($71.0m) | $30.0m | $54.0m | $95.0m | $6.0m | ($28.0m) | $55.0m | $50.0m | ($97.0m) | |
| Changes in rebate factor payable | — | — | — | — | — | — | $0 | $0 | $123.0m | ($123.0m) | |
| Changes in securities lending collateral receivable | — | — | — | — | — | — | $0 | $0 | ($418.0m) | ($220.0m) | |
| Changes in securities lending payable | — | — | — | — | — | — | $0 | $0 | $418.0m | $220.0m | |
| Debt Securities, Available-for-sale, Realized Gain (Loss) | — | — | $90.0m | $62.0m | — | $130.0m | $205.0m | $54.0m | ($24.0m) | $50.0m | |
| Debt and Equity Securities, Gain (Loss) | — | — | ($90.0m) | ($62.0m) | $838.0m | ($130.0m) | ($205.0m) | ($54.0m) | $24.0m | ($50.0m) | |
| Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal | $0 | $0 | ($786.0m) | — | — | — | — | — | — | — | |
| Equity Securities, FV-NI, Gain (Loss) | — | — | ($90.0m) | ($62.0m) | ($838.0m) | ($341.0m) | ($123.0m) | $1.0m | $0 | $50.0m | |
| Equity Securities, FV-NI, Realized Gain (Loss) | — | — | ($90.0m) | ($62.0m) | ($838.0m) | ($13.0m) | ($105.0m) | $1.0m | $0 | $50.0m | |
| Equity Securities, FV-NI, Unrealized Gain (Loss) | — | — | ($90.0m) | ($62.0m) | ($838.0m) | ($328.0m) | ($18.0m) | $0 | $0 | $50.0m | |
| Equity in net losses | $0 | $0 | ($11.0m) | ($14.0m) | ($74.0m) | ($65.0m) | $4.0m | $63.0m | $94.0m | $102.0m | |
| Fair value of assets acquired, net of cash acquired | $7.0m | $31.0m | $392.0m | $28.0m | $819.0m | $9.8b | $460.0m | $462.0m | $124.0m | $91.0m | |
| Goodwill | $3.3b | $3.3b | $3.9b | $3.9b | $4.4b | $11.1b | $9.1b | $9.6b | $9.6b | $9.7b | |
| Increase (Decrease) in Other Operating Assets | ($426.0m) | $582.0m | $484.0m | ($118.0m) | $581.0m | $491.0m | $463.0m | $1.3b | ($1.0b) | $2.2b | |
| Interest payments | $185.0m | $216.0m | $195.0m | $212.0m | $258.0m | $285.0m | $354.0m | $394.0m | $584.0m | $628.0m | |
| Less: Fair value of liabilities assumed | $0 | $0 | ($38.0m) | ($28.0m) | ($110.0m) | ($3.2b) | ($70.0m) | ($234.0m) | ($35.0m) | ($10.0m) | |
| Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims | $44.7b | $43.5b | $45.9b | $53.9b | $61.6b | $69.2b | $75.7b | $88.4b | $100.7b | $110.8b | |
| Loss (gain) on investment securities, net | — | — | ($90.0m) | ($62.0m) | ($838.0m) | $130.0m | $205.0m | $54.0m | ($24.0m) | $50.0m | |
| Loss on sale of business | $0 | $0 | $786.0m | $0 | $0 | $0 | ($237.0m) | $0 | $0 | $67.0m | |
| Other | $162.0m | $155.0m | $107.0m | — | — | — | $0 | $0 | ($50.0m) | $0 | |
| Other assets | $426.0m | ($582.0m) | ($484.0m) | $118.0m | ($581.0m) | ($491.0m) | ($463.0m) | ($1.3b) | $1.0b | ($2.2b) | |
| Other liabilities | $937.0m | $641.0m | ($676.0m) | $471.0m | $599.0m | $176.0m | $44.0m | $841.0m | ($373.0m) | $1.3b | |
| Other, net | — | $155.0m | $107.0m | $90.0m | $49.0m | $40.0m | $9.0m | ($151.0m) | ($108.0m) | ($81.0m) | |
| Proceeds from Stock Options Exercised | $11.0m | $63.0m | $50.0m | $58.0m | $61.0m | $30.0m | $51.0m | $9.0m | $300k | $0 | |
| Proceeds from issuance of senior notes, net | $0 | $1.8b | $0 | $987.0m | $1.1b | $3.0b | $2.0b | $2.5b | $2.2b | $1.5b | |
| Proceeds from sale of business, net | — | — | — | — | $0 | $0 | $2.7b | $0 | $0 | $115.0m | |
| Proceeds from short-term borrowings | $0 | $0 | $1.0b | — | — | $0 | $0 | $100.0m | $0 | $0 | |
| Receivables | ($158.0m) | $406.0m | ($200.0m) | ($32.0m) | ($85.0m) | ($280.0m) | ($54.0m) | ($337.0m) | ($669.0m) | ($570.0m) | |
| Repayment of senior notes | — | — | $0 | ($400.0m) | ($400.0m) | $0 | ($1.0b) | ($1.8b) | ($1.1b) | ($948.0m) | |
| Repayment of short-term borrowings | $0 | $0 | ($350.0m) | — | — | $0 | $0 | ($100.0m) | $0 | $0 | |
| Repayment of term loan | — | $0 | ($350.0m) | ($650.0m) | ($1.0b) | ($2.1b) | ($2.0b) | ($500.0m) | $0 | $0 | |
| Revenue from Contract with Customer, Including Assessed Tax | — | — | $1.5b | $1.4b | $1.8b | $3.1b | $4.8b | $4.0b | $4.4b | $5.8b | |
| Stock or Unit Option Plan Expense | $9.0m | $12.0m | $13.0m | $11.0m | — | — | — | — | — | — | |
| Stock-based compensation | $115.0m | $157.0m | $137.0m | $163.0m | $181.0m | $180.0m | $216.0m | $175.0m | $207.0m | $241.0m | |
| Unearned revenues | ($84.0m) | $98.0m | ($95.0m) | ($36.0m) | $71.0m | ($65.0m) | $32.0m | ($20.0m) | ($6.0m) | $96.0m | |
| Net Cash Provided by (Used in) Operating Activities | $1.9b | $4.1b | $2.2b | $5.3b | $5.6b | $2.3b | $4.6b | $4.0b | $3.0b | $921.0m | |
| Cash flows from investing activities: | |||||||||||
| Payments to Acquire Property, Plant, and Equipment | $527.0m | $526.0m | $612.0m | $736.0m | $964.0m | $1.3b | $1.1b | $1.0b | $575.0m | $546.0m | |
| Payments to Acquire Businesses, Net of Cash Acquired | $7.0m | $31.0m | $354.0m | $0 | $709.0m | $4.2b | $337.0m | $233.0m | $89.0m | $81.0m | |
| Purchases of investment securities | ($6.6b) | ($6.3b) | ($4.7b) | ($6.4b) | ($9.1b) | ($7.2b) | ($6.0b) | ($7.6b) | ($8.2b) | ($6.4b) | |
| Proceeds from maturities of investment securities | $1.4b | $1.1b | $972.0m | $1.7b | $5.0b | $2.6b | $1.4b | $1.3b | $3.0b | $2.9b | |
| Proceeds from sales of investment securities | $4.3b | $2.8b | $3.5b | $4.1b | $2.7b | $3.5b | $2.4b | $3.8b | $3.4b | $6.5b | |
| Payments for (Proceeds from) Other Investing Activities | — | — | — | — | — | — | — | — | $50.0m | $0 | |
| Net Cash Provided by (Used in) Investing Activities | ($1.4b) | ($2.9b) | ($3.1b) | ($1.3b) | ($3.1b) | ($6.6b) | ($1.0b) | ($3.5b) | ($3.0b) | $2.3b | |
| Cash flows from financing activities: | |||||||||||
| Debt issue costs | — | — | — | $0 | $0 | ($31.0m) | ($6.0m) | ($7.0m) | ($7.0m) | ($5.0m) | |
| Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale | $1.4b | $1.1b | $972.0m | $1.7b | $5.0b | $2.6b | $1.4b | $1.3b | $3.0b | $2.9b | |
| Repayments of Long-term Debt | $0 | $800.0m | $0 | $400.0m | — | — | — | — | — | — | |
| Common stock repurchases | ($104.0m) | ($3.4b) | ($1.1b) | ($1.1b) | ($1.8b) | ($79.0m) | ($2.1b) | ($1.6b) | ($817.0m) | ($151.0m) | |
| Payments for Repurchase of Common Stock | $104.0m | $3.4b | $1.1b | $1.1b | $1.8b | $79.0m | $2.1b | $1.6b | $817.0m | $151.0m | |
| Payments of Ordinary Dividends, Common Stock | $177.0m | $220.0m | $265.0m | $291.0m | $323.0m | $90.0m | $98.0m | $431.0m | $431.0m | $430.0m | |
| Less: Noncontrolling interests acquired | — | — | — | $0 | $0 | ($22.0m) | ($53.0m) | $5.0m | $0 | $0 | |
| Dividends paid | ($177) | ($220) | ($265) | ($291) | ($323) | ($354) | ($392) | ($431) | ($431) | ($430) | |
| Proceeds from (Payments for) Other Financing Activities | — | — | — | — | — | — | $9.0m | ($151.0m) | ($108.0m) | ($81.0m) | |
| Net Cash Provided by (Used in) Financing Activities | $732.0m | ($945.0m) | ($785.0m) | ($2.3b) | ($2.0b) | $3.0b | ($1.9b) | ($856.0m) | ($2.5b) | ($1.2b) | |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | $1.3b | $165.0m | ($1.7b) | $1.7b | $619.0m | ($1.3b) | $1.7b | ($367.0m) | ($2.5b) | $2.0b | |
| Increase (decrease) in cash and cash equivalents | $1.3b | $165.0m | ($1.7b) | $1.7b | $619.0m | ($1.3b) | $1.7b | ($367.0m) | ($2.5b) | $2.0b | |
| Acquisitions, net of cash and cash equivalents acquired | ($7.0m) | ($31.0m) | ($354.0m) | $0 | ($709.0m) | ($4.2b) | ($337.0m) | ($233.0m) | ($89.0m) | ($81.0m) | |
| Cash and cash equivalents at beginning of period | — | $4.0b | $2.3b | $4.1b | $4.7b | $3.4b | $5.1b | $4.7b | $2.2b | $4.2b | |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | — | — | — | $4.1b | $4.7b | $3.4b | $5.1b | $4.7b | $2.2b | $4.2b | |
| Supplemental disclosure of cash flow information: | |||||||||||
| Interest Paid, Excluding Capitalized Interest, Operating Activities | — | — | $195.0m | $212.0m | $258.0m | $285.0m | $354.0m | $394.0m | $584.0m | $628.0m | |
| Income Taxes Paid, Net | $916.0m | $1.5b | $631.0m | $518.0m | $1.1b | $227.0m | $758.0m | $997.0m | $570.0m | — |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.